Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDICT: Non-invasive Prediction of Coronary Atherosclerosis Changes
NCT01773512Phase 4Unknown
- Sponsor
- General University Hospital in Prague
- Start
- Jun 2012
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of rosuvastatin in coronary artery disease (CAD), sponsored by General University Hospital in Prague. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01773512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01773512.